Safety, pharmacokinetics, and pharmacodynamics of intravenous ferric carboxymaltose in children with iron deficiency anemia

BACKGROUND: Iron deficiency is the primary cause of anemia in children. Intravenous (IV) iron formulations circumvent malabsorption and rapidly restore hemoglobin. METHODS: This Phase 2, non-randomized, multicenter study characterized the safety profile and determined appropriate dosing of ferric ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Korczowski, Bartosz, Farrell, Colm, Falone, Mark, Blackman, Nicole, Rodgers, Trudy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2023
Materias:
Clinical Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10589089/
https://www.ncbi.nlm.nih.gov/pubmed/37208431
http://dx.doi.org/10.1038/s41390-023-02644-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10589089/
https://www.ncbi.nlm.nih.gov/pubmed/37208431
http://dx.doi.org/10.1038/s41390-023-02644-9

Ejemplares similares